Changeflow GovPing Pharma & Drug Safety EPO Patent Grant: Method for obtaining improved...
Routine Rule Added Final

EPO Patent Grant: Method for obtaining improved fitness sperm cells

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 18th, 2026
Detected March 24th, 2026
Email

Summary

The European Patent Office has granted patent EP3752597B1 for a method to obtain a sperm cell population with improved fitness. The patent is effective March 18, 2026, and covers various designated states within the European Union.

What changed

The European Patent Office (EPO) has granted patent EP3752597B1, titled 'Method for obtaining improved fitness sperm cells.' This patent, effective March 18, 2026, relates to advancements in biotechnology and reproductive health.

This grant signifies a new intellectual property right in the EU for the specified method. Companies involved in reproductive technologies, pharmaceuticals, or biotechnology may need to review this patent to assess potential impacts on their research, development, or commercial activities, particularly concerning sperm cell selection and fitness assessment.

Source document (simplified)

← EPO Patent Bulletin

METHOD FOR OBTAINING A SPERMATOZOID CELL POPULATION WITH IMPROVED FITNESS

Grant EP3752597B1 Kind: B1 Mar 18, 2026

Inventors

SUBIRÁN CIUDAD, Nerea, IRAZUSTA ASTIAZARAN, Jon, CASIS SAENZ, Luis, URIZAR ARENAZA, Itziar, MUÑOA HOYOS, Iraia, GIANZO CITORES, Marta

IPC Classifications

C12N 5/076 20100101AFI20190823BHEP C12N 5/071 20100101ALI20190823BHEP A01K 67/00 20060101ALI20190823BHEP G01N 33/68 20060101ALI20190823BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

METHOD FOR OBTAINING A SPERMATOZOID CELL POPULATION WITH IMPROVED FITNESS

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP3752597B1

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Biotechnology Research Reproductive Health
Geographic scope
European Union EU

Taxonomy

Primary area
Healthcare
Operational domain
Legal
Topics
Biotechnology Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.